2025 Chinese guideline for the imaging diagnosis and evaluation of Takayasu arteritis

Abstract Background Takayasu arteritis (TAK) presents as systemic vasculitis. Imaging is crucial for the diagnosis and evaluation of TAK, but the rational selection of imaging methods and interpretation of imaging results are major challenges in clinical practice, which can affect treatment decision...

Full description

Saved in:
Bibliographic Details
Main Authors: Yun Liu, Lingying Ma, Zhuoli Zhang, Yan Zhao, Xuerong Deng, Jiang Lin, Jianxing Qiu, Hongcheng Shi, Ke Wang, Zhu Chen, Lie Dai, Lingli Dong, Xuebing Feng, Lan He, Wenhui Huang, Fen Li, Guangtao Li, Qin Li, Ting Li, Yisha Li, Jin Lin, Jinying Lin, Wufang Qi, Haili Shen, Xiaofei Shi, Qiang Shu, Wenfeng Tan, Caihong Wang, Wei Wei, Huaxiang Wu, Lijun Wu, Qibing Xie, Pingting Yang, Liyun Zhang, Ling Zhao, Zhaohui Zheng, Wenjie Zheng, Jing Zhu, Xiaochun Zhu, Xiaoqin Wang, Jun Ying, Lindi Jiang, Chinese Rheumatology Association, Rheumatological Immunology Committee of Primary Health Care Foundation of China
Format: Article
Language:English
Published: BMC 2025-06-01
Series:Advances in Rheumatology
Subjects:
Online Access:https://doi.org/10.1186/s42358-025-00460-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850136423518175232
author Yun Liu
Lingying Ma
Zhuoli Zhang
Yan Zhao
Xuerong Deng
Jiang Lin
Jianxing Qiu
Hongcheng Shi
Ke Wang
Zhu Chen
Lie Dai
Lingli Dong
Xuebing Feng
Lan He
Wenhui Huang
Fen Li
Guangtao Li
Qin Li
Ting Li
Yisha Li
Jin Lin
Jinying Lin
Wufang Qi
Haili Shen
Xiaofei Shi
Qiang Shu
Wenfeng Tan
Caihong Wang
Wei Wei
Huaxiang Wu
Lijun Wu
Qibing Xie
Pingting Yang
Liyun Zhang
Ling Zhao
Zhaohui Zheng
Wenjie Zheng
Jing Zhu
Xiaochun Zhu
Xiaoqin Wang
Jun Ying
Lindi Jiang
Chinese Rheumatology Association
Rheumatological Immunology Committee of Primary Health Care Foundation of China
author_facet Yun Liu
Lingying Ma
Zhuoli Zhang
Yan Zhao
Xuerong Deng
Jiang Lin
Jianxing Qiu
Hongcheng Shi
Ke Wang
Zhu Chen
Lie Dai
Lingli Dong
Xuebing Feng
Lan He
Wenhui Huang
Fen Li
Guangtao Li
Qin Li
Ting Li
Yisha Li
Jin Lin
Jinying Lin
Wufang Qi
Haili Shen
Xiaofei Shi
Qiang Shu
Wenfeng Tan
Caihong Wang
Wei Wei
Huaxiang Wu
Lijun Wu
Qibing Xie
Pingting Yang
Liyun Zhang
Ling Zhao
Zhaohui Zheng
Wenjie Zheng
Jing Zhu
Xiaochun Zhu
Xiaoqin Wang
Jun Ying
Lindi Jiang
Chinese Rheumatology Association
Rheumatological Immunology Committee of Primary Health Care Foundation of China
author_sort Yun Liu
collection DOAJ
description Abstract Background Takayasu arteritis (TAK) presents as systemic vasculitis. Imaging is crucial for the diagnosis and evaluation of TAK, but the rational selection of imaging methods and interpretation of imaging results are major challenges in clinical practice, which can affect treatment decisions. This guideline aims to establish standardized protocols for selecting imaging modalities (as well as interpreting their findings) in TAK. Methods Relevant clinical questions were formulated by an expert panel. Systematic reviews of evidence published from database establishment to 31 October 2023 were done. The grading system set by the Oxford University Evidence-Based Medicine Center was employed to assess the quality of evidence. Recommendations were developed through consensus using the Delphi method. Results Seventeen recommendation statements were developed based on evidence summaries and consensus. The first four recommendations focused on overarching principles. Recommendations 5 to 14 covered the advantages and disadvantages of different imaging modalities, as well as the selection of imaging modalities in the diagnosis and evaluation of TAK, including ultrasound (three statements), magnetic resonance angiography (two), computed tomography angiography (two), positron emission tomography/computed tomography (two), and digital subtraction angiography (one). Recommendations 15 to 17 focused on the selection of imaging methods for special populations and organ perfusion. Conclusion These recommendations could help to standardize the use of imaging modalities by clinicians in the diagnosis and evaluation of TAK. Clinical trial number Not applicable.
format Article
id doaj-art-804d651cd3ea4ed5ae8e8f30329bdc6b
institution OA Journals
issn 2523-3106
language English
publishDate 2025-06-01
publisher BMC
record_format Article
series Advances in Rheumatology
spelling doaj-art-804d651cd3ea4ed5ae8e8f30329bdc6b2025-08-20T02:31:09ZengBMCAdvances in Rheumatology2523-31062025-06-0165111410.1186/s42358-025-00460-92025 Chinese guideline for the imaging diagnosis and evaluation of Takayasu arteritisYun Liu0Lingying Ma1Zhuoli Zhang2Yan Zhao3Xuerong Deng4Jiang Lin5Jianxing Qiu6Hongcheng Shi7Ke Wang8Zhu Chen9Lie Dai10Lingli Dong11Xuebing Feng12Lan He13Wenhui Huang14Fen Li15Guangtao Li16Qin Li17Ting Li18Yisha Li19Jin Lin20Jinying Lin21Wufang Qi22Haili Shen23Xiaofei Shi24Qiang Shu25Wenfeng Tan26Caihong Wang27Wei Wei28Huaxiang Wu29Lijun Wu30Qibing Xie31Pingting Yang32Liyun Zhang33Ling Zhao34Zhaohui Zheng35Wenjie Zheng36Jing Zhu37Xiaochun Zhu38Xiaoqin Wang39Jun Ying40Lindi Jiang41Chinese Rheumatology AssociationRheumatological Immunology Committee of Primary Health Care Foundation of ChinaDepartment of Rheumatology and Immunology, Zhongshan Hospital, Fudan UniversityDepartment of Rheumatology and Immunology, Zhongshan Hospital, Fudan UniversityDepartment of Rheumatology and Immunology, Peking University First HospitalDepartment of Rheumatology and Immunology, Peking Union Medical College HospitalDepartment of Rheumatology and Immunology, Peking University First HospitalDepartment of Radiology, Zhongshan Hospital, Fudan UniversityDepartment of Radiology, Peking University First HospitalDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan UniversityDepartment of Radiology, Peking University First HospitalDepartment of Rheumatology and Immunology, Anhui Medical University Affiliated Provincial HospitalDepartment of Rheumatology and Immunology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen UniversityDepartment of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Nanjing UniversityDepartment of Rheumatology and Immunology, The First Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Rheumatology and Immunology, The Second Affiliated Hospital of Guangzhou Medical UniversityDepartment of Rheumatology and Immunology, The Second Xiangya Hospital , Central South UniversityDepartment of Rheumatology and Immunology, Peking University First HospitalDepartment of Rheumatology and Immunology, The First People’s Hospital of Yunnan ProvinceDepartment of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of MedicineDepartment of Rheumatology, Xiangya Hospital, Central South UniversityDepartment of Rheumatology, The First Affiliated Hospital, Zhejiang University School of MedicineDepartment of Rheumatology and Immunology, The People’s Hospital of Guangxi Zhuang Autonomous RegionDepartment of Rheumatology, Tianjin First Central HospitalDepartment of Rheumatology, Lanzhou University Second HospitalDepartment of Rheumatology and Immunology, The First Affiliated Hospital of Henan University of Science and TechnologyDepartment of Rheumatology, Qilu Hospital, Shandong UniversityDepartment of Rheumatology, The First Affiliated Hospital of Nanjing Medical UniversityDepartment of Rheumatology, The Second Hospital of Shanxi Medical UniversityDepartment of Rheumatology and Immunology, Tianjin Medical University General HospitalDepartment of Rheumatology, The Second Affiliated Hospital, Zhejiang University School of MedicineDepartment of Rheumatology and Immunology, People’s Hospital of Xinjiang Uygur Autonomous RegionDepartment of Rheumatology and Immunology, West China Hospital, Sichuan UniversityDepartment of Rheumatology and Immunology, First Affiliated Hospital, China Medical UniversityDepartment of Rheumatology, Shanxi Bethune Hospital, Shanxi Academy of Medical SciencesDepartment of Rheumatology, The First Hospital of Jilin UniversityDepartment of Rheumatology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Rheumatology and Immunology, Peking Union Medical College HospitalDepartment of Rheumatology and Immunology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of ChinaDepartment of Rheumatology, The First Affiliated Hospital of Wenzhou Medical UniversityCenter for Evidence-based Medicine, Fudan UniversityFudan University LibraryDepartment of Rheumatology and Immunology, Zhongshan Hospital, Fudan UniversityAbstract Background Takayasu arteritis (TAK) presents as systemic vasculitis. Imaging is crucial for the diagnosis and evaluation of TAK, but the rational selection of imaging methods and interpretation of imaging results are major challenges in clinical practice, which can affect treatment decisions. This guideline aims to establish standardized protocols for selecting imaging modalities (as well as interpreting their findings) in TAK. Methods Relevant clinical questions were formulated by an expert panel. Systematic reviews of evidence published from database establishment to 31 October 2023 were done. The grading system set by the Oxford University Evidence-Based Medicine Center was employed to assess the quality of evidence. Recommendations were developed through consensus using the Delphi method. Results Seventeen recommendation statements were developed based on evidence summaries and consensus. The first four recommendations focused on overarching principles. Recommendations 5 to 14 covered the advantages and disadvantages of different imaging modalities, as well as the selection of imaging modalities in the diagnosis and evaluation of TAK, including ultrasound (three statements), magnetic resonance angiography (two), computed tomography angiography (two), positron emission tomography/computed tomography (two), and digital subtraction angiography (one). Recommendations 15 to 17 focused on the selection of imaging methods for special populations and organ perfusion. Conclusion These recommendations could help to standardize the use of imaging modalities by clinicians in the diagnosis and evaluation of TAK. Clinical trial number Not applicable.https://doi.org/10.1186/s42358-025-00460-9Takayasu arteritisImaging methodGuidelineDiagnosisAssessment
spellingShingle Yun Liu
Lingying Ma
Zhuoli Zhang
Yan Zhao
Xuerong Deng
Jiang Lin
Jianxing Qiu
Hongcheng Shi
Ke Wang
Zhu Chen
Lie Dai
Lingli Dong
Xuebing Feng
Lan He
Wenhui Huang
Fen Li
Guangtao Li
Qin Li
Ting Li
Yisha Li
Jin Lin
Jinying Lin
Wufang Qi
Haili Shen
Xiaofei Shi
Qiang Shu
Wenfeng Tan
Caihong Wang
Wei Wei
Huaxiang Wu
Lijun Wu
Qibing Xie
Pingting Yang
Liyun Zhang
Ling Zhao
Zhaohui Zheng
Wenjie Zheng
Jing Zhu
Xiaochun Zhu
Xiaoqin Wang
Jun Ying
Lindi Jiang
Chinese Rheumatology Association
Rheumatological Immunology Committee of Primary Health Care Foundation of China
2025 Chinese guideline for the imaging diagnosis and evaluation of Takayasu arteritis
Advances in Rheumatology
Takayasu arteritis
Imaging method
Guideline
Diagnosis
Assessment
title 2025 Chinese guideline for the imaging diagnosis and evaluation of Takayasu arteritis
title_full 2025 Chinese guideline for the imaging diagnosis and evaluation of Takayasu arteritis
title_fullStr 2025 Chinese guideline for the imaging diagnosis and evaluation of Takayasu arteritis
title_full_unstemmed 2025 Chinese guideline for the imaging diagnosis and evaluation of Takayasu arteritis
title_short 2025 Chinese guideline for the imaging diagnosis and evaluation of Takayasu arteritis
title_sort 2025 chinese guideline for the imaging diagnosis and evaluation of takayasu arteritis
topic Takayasu arteritis
Imaging method
Guideline
Diagnosis
Assessment
url https://doi.org/10.1186/s42358-025-00460-9
work_keys_str_mv AT yunliu 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT lingyingma 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT zhuolizhang 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT yanzhao 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT xuerongdeng 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT jianglin 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT jianxingqiu 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT hongchengshi 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT kewang 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT zhuchen 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT liedai 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT linglidong 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT xuebingfeng 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT lanhe 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT wenhuihuang 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT fenli 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT guangtaoli 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT qinli 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT tingli 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT yishali 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT jinlin 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT jinyinglin 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT wufangqi 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT hailishen 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT xiaofeishi 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT qiangshu 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT wenfengtan 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT caihongwang 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT weiwei 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT huaxiangwu 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT lijunwu 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT qibingxie 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT pingtingyang 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT liyunzhang 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT lingzhao 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT zhaohuizheng 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT wenjiezheng 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT jingzhu 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT xiaochunzhu 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT xiaoqinwang 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT junying 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT lindijiang 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT chineserheumatologyassociation 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis
AT rheumatologicalimmunologycommitteeofprimaryhealthcarefoundationofchina 2025chineseguidelinefortheimagingdiagnosisandevaluationoftakayasuarteritis